All Friedrich-Alexander-University Erlangen-Nürnberg articles
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
